Archive \ Volume.14 2023 Issue 3

Post-acute COVID-19- Related Cough Syncope: A Case Report from Saudi Arabia


Abstract

A 41-year-old male unvaccinated for COVID-19 presented to the emergency department with syncope due to a severe cough, 2 weeks after recovering from COVID-19 for the second time. He demonstrated symptoms of wheezing during the physical exam. However, vitals, lab findings, and the chest CT scan were normal. He was started on proton-pump inhibitors, inhaled antimuscarinic and gabapentin drugs for 7 days on top of a short course of antibiotics, and oral as well as inhaled steroids. His syncopial cough episodes have subsided completely and remain stable. Therefore, clinicians should be aware of the uncommon complication of COVID-19 in the post-acute phase of the disease. Possible predictive factors for syncopal cough are young age, history of COVID-19 infection, as he has been infected twice, and not receiving a COVID-19 vaccine. Gabapentin and antimuscarinic agents may play roles in managing COVID-19-related cough syncope and should be used as part of a multimodal intervention that targets cough, mainly to shorten cough syncope episodes in surviving patients.


Downloads: 153
Views: 463

How to cite:
Vancouver
Almalki OS. Post-acute COVID-19- Related Cough Syncope: A Case Report from Saudi Arabia. Arch Pharm Pract. 2023;14(3):67-9. https://doi.org/10.51847/1xmiiG3ieY
APA
Almalki, O. S. (2023). Post-acute COVID-19- Related Cough Syncope: A Case Report from Saudi Arabia. Archives of Pharmacy Practice, 14(3), 67-69. https://doi.org/10.51847/1xmiiG3ieY

Download Citation
References
  1. de Freitas RF, Torres SC, Martín-Sánchez FJ, Carbó AV, Lauria G, Nunes JP. Syncope and COVID-19 disease - A systematic review. Auton Neurosci.  2021;235:102872.
  2. Santacroce L, Charitos IA, Carretta DM, De Nitto E, Lovero R. The human coronaviruses (HCoVs) and the molecular mechanisms of SARS-CoV-2 infection. J Mol Med. 2021;99(1):93-106.
  3. Organization WH. WHO Coronavirus (COVID-19) Dashboard. 2021. Available from: https://covid19.who.int/ on July 11, 2023.
  4. Terpos E, Ntanasis‐Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M, et al. Hematological findings and complications of COVID‐19. Am J Hematol. 2020;95(7):834-47.
  5. Cardiology ESo ESC guidelines for the diagnosis and management of syncope. Eur Heart J. 2018;39(21):1883-948.
  6. Oates CP, Turagam MK, Musikantow D, Chu E, Shivamurthy P, Lampert J, et al. Syncope and presyncope in patients with COVID‐19. Pacing Clin Electrophysiol. 2020;43(10):1139-48.
  7. Chou SH, Beghi E, Helbok R, Moro E, Sampson J, Altamirano V, et al. Global prevalence of neurological manifestations among patients hospitalized with COVID-19: a report of the global consortium study of neurologic dysfunction in COVID-19 (GCS-NeuroCOVID) and the European Academy of Neurology. JAMA Netw Open. 2021;4(5):e2112131.
  8. Kanjwal K, Jamal S, Kichloo A, Grubb BP. New-onset postural orthostatic tachycardia syndrome following coronavirus disease 2019 infection. J Innov Cardiac Rhythm Manag. 2020;11(11):4302.
  9. Miglis MG, Prieto T, Shaik R, Muppidi S, Sinn DI, Jaradeh S. A case report of postural tachycardia syndrome after COVID-19. Clin Auton Res. 2020;30(5):449-51.
  10. Martín-Sánchez FJ, Del Toro E, Cardassay E, Valls Carbo A, Cuesta F, Vigara M, et al. Clinical presentation and outcome across age categories among patients with COVID-19 admitted to a Spanish emergency department. Eur Geriatr Med. 2020;11(5):829-41.
  11. Canetta C, Accordino S, Buscarini E, Benelli G, La Piana G, Scartabellati A, et al. Syncope at SARS-CoV-2 onset. Auton Neurosci. 2020;229:102734.
  12. Baker J, Incognito AV, Wilson RJ, Raj SR. Syncope and silent hypoxemia in COVID-19: Implications for the autonomic field. Auton Neurosci. 2021;235:102842.
  13. Waldmann V, Combes N, Narayanan K, Sharifzadehgan A, Bouzeman A, Beganton F, et al. Cough Syncope. Am J Med. 2017;130(7):e295-6.
  14. Ryan NM, Birring SS, Gibson PG. Gabapentin for refractory chronic cough: a randomized, double-blind, placebo-controlled trial. Lancet. 2012;380(9853):1583-9.
  15. Vertigan AE, Kapela SL, Ryan NM, Birring SS, McElduff P, Gibson PG. Pregabalin and speech pathology combination therapy for refractory chronic cough: a randomized controlled trial. Chest. 2016;149(3):639-48.
  16. Dicpinigaitis PV, Spinner L, Santhyadka G, Negassa A. Effect of tiotropium on cough reflex sensitivity in acute viral cough. Lung. 2008;186:369-74.
  17. Song WJ, Hui CK, Hull JH, Birring SS, McGarvey L, Mazzone SB, et al. Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses. Lancet Respir Med. 2021;9(5):533-44.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.